Obeticholic Acid
Brand name: Ocaliva
Rank #292 of 500 drugs by total cost
$40.6M
Total Cost
4,131
Total Claims
$40.6M
Total Cost
254
Prescribers
$9,818
Cost per Claim
0
Beneficiaries
4,497
30-Day Fills
$160K
Avg Cost/Provider
16
Avg Claims/Provider
About Obeticholic Acid
Obeticholic Acid (sold as Ocaliva) was prescribed 4,131 times by 254 Medicare Part D providers in 2023, costing the program $40.6M. At $9,818 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
| 290 | Suvorexant (Belsomra) | $40.7M | 87,327 |
| 291 | Atogepant (Qulipta) | $40.7M | 32,955 |
| 292 | Obeticholic Acid (Ocaliva) | $40.6M | 4,131 |
| 293 | Doxycycline Hyclate (Doxycycline Hyclate) | $40.5M | 2,023,357 |
| 294 | Carbamazepine (Carbamazepine) | $40.4M | 389,090 |
| 295 | Methylnaltrexone Bromide (Relistor) | $39.8M | 16,356 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology